The deregulated NF-κB activity leads to inflammatory bowel disease, Crohn’s disease, neurodegenerative disorders, including Alzheimer’s disease and various types of cancers [25,75]. Here, NFKB1 is linked to early-onset autosomal dominant Alzheimer disease.